BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 22045184)

  • 1. Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network.
    Smith A; Howell D; Patmore R; Jack A; Roman E
    Br J Cancer; 2011 Nov; 105(11):1684-92. PubMed ID: 22045184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research.
    Smith A; Roman E; Howell D; Jones R; Patmore R; Jack A;
    Br J Haematol; 2010 Mar; 148(5):739-53. PubMed ID: 19958356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK's Haematological Malignancy Research Network.
    Smith A; Crouch S; Lax S; Li J; Painter D; Howell D; Patmore R; Jack A; Roman E
    Br J Cancer; 2015 Apr; 112(9):1575-84. PubMed ID: 25867256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of haematological malignancies, Eastern Cape Province; South Africa, 2004-2013.
    Oelofse D; Truter I
    Cancer Epidemiol; 2018 Apr; 53():166-171. PubMed ID: 29462765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating the prevalence of hematological malignancies and precursor conditions using data from Haematological Malignancy Research Network (HMRN).
    Li J; Smith A; Crouch S; Oliver S; Roman E
    Cancer Causes Control; 2016 Aug; 27(8):1019-26. PubMed ID: 27351920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphoid blood cancers, incidence and survival 2005-2023: A report from the UK's Haematological Malignancy Research Network.
    Lamb M; Painter D; Howell D; Barrans S; Cargo C; de Tute R; Tooze R; Burton C; Patmore R; Roman E; Smith A
    Cancer Epidemiol; 2024 Feb; 88():102513. PubMed ID: 38160571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wage-subsidised employment as a result of permanently reduced work capacity in a nationwide cohort of patients diagnosed with haematological malignancies.
    Horsboel TA; Nielsen CV; Nielsen B; Andersen NT; De Thurah A
    Acta Oncol; 2015 May; 54(5):743-9. PubMed ID: 25752974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive study of the epidemiology of haematological malignancies in North Queensland.
    Nath K; Boles R; Emeto TI; Adegboye OA; Castellanos ME; Alele FO; Pearce J; Ewart B; Ward K; Lai HC; Morris E; Hodges G; Irving I
    Intern Med J; 2023 Apr; 53(4):540-549. PubMed ID: 34668307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An experience with sixty cases of haematological malignancies; a clinico haematological correlation.
    Idris M; Shah SH; Fareed J; Gul N
    J Ayub Med Coll Abbottabad; 2004; 16(4):51-4. PubMed ID: 15762065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 in children with haematological malignancies.
    Millen GC; Arnold R; Cazier JB; Curley H; Feltbower R; Gamble A; Glaser A; Grundy RG; Kirton L; Lee LYW; McCabe MG; Palles C; Phillips B; Stiller CA; Varnai C; Kearns P
    Arch Dis Child; 2022 Feb; 107(2):186-188. PubMed ID: 34301621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Incidence of haematological neoplasms in Castilla y León, Spain].
    Rodríguez-García JA; Vázquez L; Ramos F; Cuevas B; Martín A; Smucler A; Guerola DN; Cantalapiedra A; Alonso JM; Fernández S; Díez E; Rodríguez MJ; Calmuntia MJ; Aguilar C; Sierra M; Gracia JA; Cebeira MJ; Cantalejo R;
    Med Clin (Barc); 2015 Jun; 144(11):491-500. PubMed ID: 25015251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK's population-based Haematological Malignancy Research Network 2004-15.
    Roman E; Smith A; Appleton S; Crouch S; Kelly R; Kinsey S; Cargo C; Patmore R
    Cancer Epidemiol; 2016 Jun; 42():186-98. PubMed ID: 27090942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards optimal clinical and epidemiological registration of haematological malignancies: Guidelines for recording progressions, transformations and multiple diagnoses.
    Gavin A; Rous B; Marcos-Gragera R; Middleton R; Steliarova-Foucher E; Maynadie M; Zanetti R; Visser O;
    Eur J Cancer; 2015 Jun; 51(9):1109-22. PubMed ID: 24630945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased risk of zoonotic Salmonella and Campylobacter gastroenteritis in patients with haematological malignancies: a population-based study.
    Gradel KO; Nørgaard M; Dethlefsen C; Schønheyder HC; Kristensen B; Ejlertsen T; Nielsen H
    Ann Hematol; 2009 Aug; 88(8):761-7. PubMed ID: 19083236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How many patients with haematological malignancy need the facilities offered by a district general hospital?
    Low J; Smith A; George S; Roderick P; Davis C
    J Public Health Med; 2002 Sep; 24(3):196-9. PubMed ID: 12831089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of disability pension for patients diagnosed with haematological malignancies: a register-based cohort study.
    Horsboel TA; Nielsen CV; Andersen NT; Nielsen B; de Thurah A
    Acta Oncol; 2014 Jun; 53(6):724-34. PubMed ID: 24456498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haematological cancers: improving outcomes. A summary of updated NICE service guidance in relation to Specialist Integrated Haematological Malignancy Diagnostic Services (SIHMDS).
    Snowden JA; O'Connell S; Hawkins J; Dalley C; Jack A; Mannari D; McNamara C; Scott M; Shenton G; Soilleux E; Macbeth F;
    J Clin Pathol; 2017 Jun; 70(6):461-468. PubMed ID: 28389440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alcohol drinking, tobacco smoking and subtypes of haematological malignancy in the UK Million Women Study.
    Kroll ME; Murphy F; Pirie K; Reeves GK; Green J; Beral V;
    Br J Cancer; 2012 Aug; 107(5):879-87. PubMed ID: 22878373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.